The receptor activator of nuclear factor- (NF-) κB (RANK); its ligand (RANKL); and the antagonist, osteoprotegerin (OPG); comprise an important cytokine system within the bone microenvironment that can mediate tumor growth. Here, TNFSF11 is linked to neoplasm.